E I D Parry India (EIDPARRY) Q1 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 24/25 earnings summary
27 Aug, 2025Executive summary
Consolidated revenue from operations for Q1 FY25 was ₹6,747 crore, down 4% year-over-year from ₹7,026 crore.
Consolidated EBITDA for the quarter was ₹528 crore, a 19% decrease from ₹652 crore in the prior year.
Consolidated profit after tax and non-controlling interest was ₹225 crore, compared to ₹325 crore in Q1 FY24.
Standalone revenue grew to ₹751 crore from ₹698 crore year-over-year, but standalone loss after tax widened to ₹79 crore from a profit of ₹46 crore.
Financial highlights
Standalone revenue from operations: ₹751 crore (Q1 FY25), up from ₹698 crore (Q1 FY24).
Standalone loss after tax: ₹79 crore (Q1 FY25) vs. profit of ₹46 crore (Q1 FY24).
Consolidated revenue from operations: ₹6,747 crore (Q1 FY25), down from ₹7,026 crore (Q1 FY24).
Consolidated profit after tax attributable to owners: ₹225 crore (Q1 FY25) vs. ₹325 crore (Q1 FY24).
Consolidated EBITDA: ₹528 crore (Q1 FY25) vs. ₹652 crore (Q1 FY24).
Outlook and guidance
Consumer Products Group achieved 67% revenue growth, driven by new product launches.
Distillery segment revenues increased due to the operationalization of the Haliyal 120 KLPD plant.
Management expects continued focus on branded staples and sweeteners, and further expansion in distillery and nutraceuticals.
Latest events from E I D Parry India
- Q3 FY26 revenue up 18% YoY; profit at Rs. 232 Cr; volumes down, realizations and distillery up.EIDPARRY
Q3 25/2613 Feb 2026 - Q3 FY25 revenue up 12% YoY to ₹8,720 crore; EBITDA up 79%; strong CPG and distillery growth.EIDPARRY
Q3 24/2516 Dec 2025 - Improved realizations and distillery gains offset lower volumes; revenue and profit increased.EIDPARRY
Q1 25/2623 Nov 2025 - Consolidated revenue rose to Rs. 31,609 crore, but net loss followed major impairment.EIDPARRY
Q4 24/2521 Nov 2025 - H1 FY26 profitability rose on higher realizations and cost control, despite volume pressures.EIDPARRY
Q2 25/2611 Nov 2025 - Revenue up, profits down; distillery and retail strong, borrowings rise, nutraceuticals weak.EIDPARRY
Q2 24/2527 Aug 2025